This announcement is a separate document:
盘龙药业：中泰证券股份有限公司关于陕西盘龙药业集团股份有限公司2023年度持续督导保荐工作报告
Shaanxi Panlong Pharmaceutical: Report of Zhongtai Securities Co., Ltd. on the 2023 continuous supervision and sponsorship work of Shaanxi Panlong Pharmaceutical Group Co., Ltd.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.